A Pilot rTMS Trial for Neuropsychiatric Symptoms of Long-COVID
NCT: NCT06586398 · COMPLETED
Brief Summary
This is a pilot randomized trial of rTMS for symptoms of fatigue and brain fog, and other neuropsychiatric symptoms of Long-COVID (Post-COVID, post-acute sequelae of COVID-19 infection, PASC). Twenty participants diagnosed with Long-COVID and recruited from the UCLA Long-COVID clinic will be randomized to receive active rTMS versus sham stimulation for 15 treatments followed by another 15 open-label rTMS treatments. Investigators will compare the safety and tolerability of rTMS vs Sham and examine within-group changes in symptoms of fatigue, sleep, pain, mood, and subjective and objective cognitive impairment. This project will provide information and pilot data for future larger clinical trials.
Frequently Asked Questions
What is A Pilot rTMS Trial for Neuropsychiatric Symptoms of Long-COVID?
A Pilot rTMS Trial for Neuropsychiatric Symptoms of Long-COVID is a clinical trial registered under NCT06586398. Current status: COMPLETED.
What is the status of NCT06586398?
The current status of NCT06586398 (A Pilot rTMS Trial for Neuropsychiatric Symptoms of Long-COVID) is: COMPLETED.
When did A Pilot rTMS Trial for Neuropsychiatric Symptoms of Long-COVID start?
A Pilot rTMS Trial for Neuropsychiatric Symptoms of Long-COVID started on 2025-01-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.